Vergent Bioscience makes biotech to spot tumors; it just raised $21.5 million

Founded in 2016, the company is developing a molecule that makes a tumor glow using a fluorescent imaging agent, allowing surgeons to more easily see and remove the tumors.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.